CA
NZ
UK
AU
IND
US
This move highlights her strategy to capitalize on short-term rallies even as her flagship Ark Innovation ETF faces ongoing pressure, down 8.51% year-to-date as of July 31. With the S&P 500 gaining 9.41% in the same timeframe, investors are keenly watching how Wood’s trading …
Recent commentary from notable analysts has characterized current trends as favorable for stocks, encouraging investments in this ETF. Investors are increasingly drawn to the fund as it aligns with broader bullish sentiments in the market, making it an appealing option for those looking to …
Banca Mediolanum S.p.A. Outlined the challenges of Q2 2026 during its earnings call on July 30, focusing on shiftingInterest Rateexpectations and geopolitical pressures. CEO Massimo Doris reported heightened energy prices and market volatility as key factors affecting performance. The commentary underlined the interconnectedness of …
Autolus Therapeutics plc (NASDAQ: AUTL) closed a senior secured notes facility worth up to $250 million and immediately issued a $75 million first tranche, dramatically widening its cash resources. The agreement also authorizes three additional tranches totalling $175 million, contingent on future revenue milestones.
DailyJournalCorp shares fell 0.3% to $592.51 in pre-market trading, a reflection of slight profit-taking among investors. Despite this pullback, the stock has surged 18.5% year-to-date, indicating strong underlying investor sentiment and competitive positioning within the sector.Key HighlightsPrice $592.51 (−0.3% today) · Mkt cap $819 …
The company posted a net loss of $20.2 million for the quarter, after incurring $16.4 million inResearch and Developmentcosts and $5.8 million in general and administrative expenses. ThisLiquiditycushion and ongoing trial activity suggest the firm can sustain its development timeline without immediate fundraising pressure.
Affirm Holdings Inc. (NASDAQ: AFRM) demonstrated a significant rebound in investor confidence, announcing an impressive 146% growth in its Affirm Card gross merchandise volume to $2.13 billion. The growth in spending on its platform reflects a restoration of optimism among consumers and investors alike. …
Indivior Pharmaceuticals (Nasdaq: INDV) posted Q2 earnings per share of $0.96, topping the $0.67 consensus estimate. The earnings beat came alongside a $175 million share repurchase program, a sum that represents roughly 4% of the company’s $4.9 billion market value. The combination of an …
Indivior Pharmaceuticals (Nasdaq: INDV) announced it will merge with Supernus Pharmaceuticals, converting each Supernus share into 1.5401 Indivior shares. The deal will leave Indivior owners with about 56.5% of the combined firm, while a $1 billion special cash dividend will be paid to shareholders …
AmBase Corp (OTC: ABCP) has received a vital boost of $1 million specifically allocated for working capital needs and ongoing litigation related to the 111 West 57th Property. This funding from Richard A. Bianco, the company's Chairman, enhances AmBase's financial resources, essential for managing …
Please wait processing your request...